Streetbeat News

Partnerships

SXTP

60 Degrees Pharmaceuticals has signed clinical trial agreements with Yale University, Rhode Island Hospital, and Tufts Medical Center for a study on Tafenoquine for Babesiosis. Patient enrollment has begun, with interim results expected by September 2025. The market for ARAKODA® (tafenoquine) for babesiosis is approximately 400,000 patients in the U.S.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2024 | 12:30 pm

RTX

Pratt & Whitney, a business unit of RTX, and SR Technics have announced the induction of the first Pratt & Whitney GTF engine at SR Technics' Zurich facility. This makes it the 17th active facility in the GTF MRO network, providing full disassembly, assembly, and test capabilities for the PW1100G-JM engine used in the Airbus A320neo aircraft family.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2024 | 12:21 pm

FBIO

Fortress Biotech's Urica Therapeutics has entered into an APA royalty agreement, selling the rights to its URAT1 inhibitor product candidate, Dotinurad, and related intellectual property to Crystalys Therapeutics in exchange for 35% of Crystalys' outstanding equity.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2024 | 12:07 pm

CMND

Clearmind Medicine has entered into a partnership to source global manufacturers and distributors for its MEAI-based alcohol substitute beverages, marking a significant step towards international expansion.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2024 | 12:01 pm

TLRY

Tilray Brands' subsidiary, SweetWater Brewing, has launched a new Rowdy Peach IPA in collaboration with Atlanta United FC.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2024 | 11:04 am

AVGO

MSFT

NVDA

OpenAI is in discussions with Broadcom to co-develop a new AI chip, aiming to reduce its reliance on Nvidia. This move is part of OpenAI's strategy to secure necessary resources for its AI models and strengthen its supply chain.

Portfolio Pulse from Benzinga Neuro

July 19, 2024 | 10:42 am

EHang Holdings has signed an agreement with KC Smart Mobility to promote the sale and operation of its EH216-s pilotless eVTOL in Hong Kong and Macau.

Portfolio Pulse from Benzinga Newsdesk

July 19, 2024 | 10:21 am

IAI

JPM

KBWB

Goldman Sachs has made several senior leadership appointments within its investment banking team, including hiring former JPMorgan banker Carsten Woehrn and appointing Nimesh Khiroya and Haidee Lee to key M&A roles. The company also reported strong second-quarter earnings, beating consensus estimates. Investors can gain exposure to Goldman Sachs through ETFs like IShares U.S. Broker-Dealers & Securities Exchanges ETF (IAI) and Invesco KBW Bank ETF (KBWB).

Portfolio Pulse from Lekha Gupta

July 19, 2024 | 10:05 am

GOOG

GOOGL

NFLX

Netflix Inc. (NASDAQ:NFLX) is targeting a larger share of the TV market and views Alphabet Inc.'s (NASDAQ:GOOG, NASDAQ:GOOGL) YouTube as both a competitor and a partner. Netflix's co-CEO Ted Sarandos highlighted that Netflix and YouTube together account for about 50% of all TV streaming in the U.S. Netflix aims to capture the remaining 80% of TV time. The company reported a successful second quarter with $9.56 billion in revenue, surpassing estimates, and has discontinued its most affordable ad-free subscription plan in the U.S. and France.

Portfolio Pulse from Ananya Gairola

July 19, 2024 | 5:44 am

AMGN

HRTS

LLY

NVO

PFE

TERN

VKTX

Eli Lilly and Novo Nordisk faced significant stock declines as new competitors entered the weight-loss drug market. Pfizer and Roche announced advancements in obesity treatments, challenging the duopoly of Eli Lilly's Zepbound and Novo Nordisk's Wegovy. The Tema GLP-1, Obesity and Cardiometabolic ETF (HRTS) fund reflects a diversified approach, investing in emerging GLP-1 players like Amgen, Terns Pharmaceuticals, and Viking Therapeutics.

Portfolio Pulse from Piero Cingari

July 18, 2024 | 8:59 pm